Optimizing adherence to allopurinol for gout: patients' perspectives - Spragg - 2023 - British Journal of Clinical Pharmacology - Wiley Online Library
JCM | Free Full-Text | Cardiovascular Safety Evaluation of Febuxostat and Allopurinol: Findings from the FDA Adverse Event Reporting System
What Is Allopurinol Used For?
Effects of febuxostat and allopurinol on the inflammation and cardiac function in chronic heart failure patients with hyperuricemia - ScienceDirect
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial - The Lancet
No-Uric 100 mg Tablet 50pcs
Allopurinol hypersensitivity: investigating the cause and minimizing the risk | Nature Reviews Rheumatology
Allopurinol | PPT
Antioxidants | Free Full-Text | Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD
ALLOPURINOL - Australian Rheumatology Association
Allopurinol and its active metabolite inhibit xanthine ... | GrepMed
Allopurinol Side Effects: Common, Severe, Long Term
Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout - ScienceDirect
Allopurinol | PPT
Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease | Scientific Reports